* Aytu Bioscience Inc files for mixed shelf of upto $100
Source text: [http://bit.ly/2B3AW23]
Further company coverage:
* Aytu Bioscience receives market approval from the
therapeutic goods administration for the Mioxsys® system for
* Aytu Bioscience Inc - on October 26, 2017, Gregory A.
Gould resigned as Chief Financial Officer